5 Best Growth Stocks to Buy According to Ray Dalio

4. Intuitive Surgical, Inc. (NASDAQ:ISRG)

Number of Hedge Fund Holders: 56

Intuitive Surgical, Inc. (NASDAQ:ISRG) is a California-based company that provides access minimally invasive care in the United States and internationally. Ray Dalio’s hedge fund owns 599,155 Intuitive Surgical, Inc. (NASDAQ:ISRG) shares as of Q2 2022, worth over $120 million and representing 0.50% of the total 13F portfolio. Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best growth stocks according to Ray Dalio. 

On September 9, Stifel analyst Rick Wise raised the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $260 from $250 and reiterated a Buy rating on the shares. Driven by a detailed U.S. and international recurring-revenue model, he lifted his 2023 sales and EPS estimates, the analyst told investors. He also noted that adoption for Ion, Intuitive Surgical, Inc. (NASDAQ:ISRG)’s robotic lung biopsy platform, is in-line with his “most-aggressive” initial diligence scenario. Similarly, Citi analyst Joanne Wuensch on October 5 maintained a Buy rating on the stock and lowered the price target to $237 from $243. 

According to Insider Monkey’s data, 56 hedge funds were long Intuitive Surgical, Inc. (NASDAQ:ISRG) at the end of June 2022, compared to 65 funds in the earlier quarter. Ken Fisher’s Fisher Asset Management featured as the leading stakeholder of the company, with 4.60 million shares worth $923.3 million. 

Here is what Baron Health Care Fund has to say about Intuitive Surgical, Inc. (NASDAQ:ISRG) in its Q2 2022 investor letter:

“Intuitive Surgical, Inc. markets the da Vinci Surgical System, a robotic system used for minimally invasive surgical procedures. The stock declined along with other premium valuation, high-growth names due to investor concerns around inflation and rising interest rates. The potential for a more challenging sales environment for Intuitive’s hospital customer base also played a role. We continue to believe Intuitive has a long runway to expand the number of procedures performed using its robotic system.”